The differential expression of Ia antigens was studied in freshly isolated rheumatoid nonlymphoid synovial lining cells (SLC) 
resulting in a multicellular layer of synovial cells and the invasion of cartilage and bone structures by cells presumably derived from these populations. With immunological reagents to probe the structure ofthe rheumatoid synovial membrane, the most striking finding proved to be the intense expression of Ia antigens (class II HLA molecules) on the majority of synovial lining cells (1) (2) (3) (4) . A further dissection ofthis heterogenous cell population demonstrated that the majority of Ia-positive cells belong to the monocyte/macrophage lineage. These cells, termed "type I" and identifiable with the type A synovial cells, bear typical monocyte lineage antigens, express Fc receptors, and frequently have a morphology characterized by an elongated cell shape with long cell processes (1, 5) . This cell population is found both in the rheumatoid synovium and within apparently normal synovial tissue derived from patients with noninflammatory joint diseases (1, 2 ).
An additional Ia-positive cell population, detectable primarily in the rheumatoid synovium and termed "type II" cells, is characterized by the intense expression of these class II molecules, but also by the absence of markers characteristic of the monocyte lineage. These cells frequently have a dendritic shape and lose the expression of Ia antigens upon culture (1, 5) . The origin ofthese cells is not clear. Whereas the Ia-positive phenotype along with their dendritic morphology would make them similar to the classic dendritic cells described by Steinman et al. (6) , the facts that the majority of synovial dendritic cells are poor inducers of the mixed leukocyte reaction (7) , rapidly lose Ia antigens upon culture (1, 5) , and produce large amounts of collagenase (8, 9) would rather suggest a relationship to the fibroblast lineage.
A possible aid to delineate the origin of these cells may be the analysis of Ia antigen expression, in particular studying the gene products of the various Ia loci. This is suggested by the findings that not all Ia molecules are expressed in equal amounts on the cell surface. Thus, a divergent expression of DR and DQ class II molecules has been described on peripheral blood monocytes (10) and certain tissue cells (11) . In addition, investigating the differential Ta antigen expression of synovial cells after incubation with Interferon-y, which has recently been shown to be a potent Ta antigen inducer on these cells ( 12) , may shed light on a possible role of this mediator in an in vivo situation.
Methods
Patient population. 12 patients (nine female, three male) with definite or classic rheumatoid arthritis according to American Rheumatism Association criteria were studied. The majority of patients had received antiinflammatory nonsteroidal drugs that had been discontinued at least 12 h before surgery. Patients on a current treatment with gold salts, other remission-inducing drugs, or steroids were excluded from study.
Two synovial specimens from amputation material from patients without apparent joint diseases were included as normal counterparts to the patient group with rheumatoid arthritis. Peripheral blood monocytes were derived from nine patients with rheumatoid arthritis and nine normal donors.
Processing ofsynovial tissue and cell isolation. Synovial tissue obtained at reconstructive surgery was finely minced and incubated with RPMI medium 1640 containing 1 mg/ml collagenase (Sigma Chemical Co., St. Louis, MO) and 0.15 mg/ml DNAse (Sigma Chemical Co.), as previously described in detail (1) . After 60-90 min at 370C, the resulting cell suspension was purified upon Ficoll/Isopaque density gradients (1) . Nonlymphoid synovial cells (SLC)' were enriched by means of a discontinuous Percoll (Pharmacia Inc., Piscataway, NJ) density gradient, as reported previously (1) . Cells were harvested from the interface between 20 and 50% Percoll, washed three times, and stored in RPMI 1640 supplemented with 10% fetal calfserum (FCS) or cultured in tissue culture flasks, respectively, to study the cell morphology. This cell population contained < 5% of cells with lymphoid characteristics as determined by morphology or staining with monoclonal antibodies directed towards T or B lymphocytes (see below). The viability exceeded 95%. Peripheral blood non-T cells were separated using neuraminidase-treated sheep red blood cells (E) (13) .
Peripheral blood monocytes with a purity of > 90% as determined by reagent Leu M3 (14) were obtained using Nycodenz (Nyegaard Diagnostica, Oslo, Norway) gradient (d 1.068 g/ml) centrifugation of peripheral blood mononuclear cells previously incubated in autologous EDTA-plasma according to product literature.
Peripheral blood B cells were isolated from monocyte-depleted peripheral blood mononuclear cells using Nylon wool columns resulting in a cell population with > 80% surface immunoglobulin-positive cells (13) .
Cell cultures and identification ofcell populations. Synovial lining cells were cultured in two ways. (a) Immediately after isolation, SLC were distributed to 24-well tissue culture plates (Nunc, Roskilde, Denmark) containing medium RPMI 1640, supplemented with 10% FCS, and allowed to adhere to glass cover slips (Bellco Glass, Inc., Vineland, NJ), which had previously been placed into the wells, for -3 h (5). Latex particles were added to identify phagocytic cells (1) . Subsequently, the cover slips were taken out, washed thoroughly, and used for immunofluorescence staining as previously described (15) . Immediately after the final washing step, the cover slips were examined by means of a Epifluorescence Microscope (Orthoplan II; E. Leitz, Inc., Rockleigh, NJ) equipped with phase-contrast optics.
(b) SLC were cultured in regular culture flasks for about two or three passages until the proportion of cells bearing monocyte markers or Ia antigens was < 1% as determined by the antimonocyte reagent Leu M3 (=M4 P-9) or by OKIa 1. Subsequently, cells were split into equal portions with one part cultured as before and the second part treated with 200 U/ml of recombinant Interferon--y (kindly provided by Dr. Papendieck, Thomae Co., Biberach, FRG, and produced by Genentech Inc., San Francisco, CA) for a period of 7 d. Preliminary kinetic experiments with concentrations of 1-1,000 U/ml and periods of 1-9 d had indicated that maximum Ia antigen expression was achieved using these culture conditions (data not shown). After culture, cells were trypsinized, stained in parallel, and Ia antigen expression was studied using both the fluorescence microscope and the fluorescence-activated cell sorter.
Identification ofcell surface antigens. Characteristics of the monoclonal anti-Ia reagents are outlined in Table I (26] ), whereas B cells were detected by surface immunoglobulin staining (27) . All the reagents described above were used in concentrations that had been shown in extensive preliminary studies to be saturating using the fluorescence-activated cell sorter.
Immunofluorescence. The aforementioned monoclonal reagents were used in indirect immunofluorescence as previously reported, either utilizing the fluorescence microscope (E. Leitz ities on SLC was in accordance with results determining positivity on the corresponding peripheral blood non-T cells (data not shown). However, of special interest, the number of positive cells as determined by the monomorphic reagents HLA-DR or Leu 10, respectively, was frequently higher than the percentages of positive cells as measured by the polymorphic reagents identifying epitopes belonging to the same Ia antigen family. Thus, for instance in patient 1 in Fig. 1 , 58% ofthe cells expressed the epitope detected by reagent HLA-DR, whereas only 35% of cells were positive for antibody IL-R2 detecting the DRw52 specificity (see Table I ). Because of the individual HLA type of this patient, the cells were negative for reagent 109 d6.
Similar data within the DQ antigen family were obtained in patient 2 (Leu 10+ cells > Genox 353+ cells) and patient 8 (Leu I0+ cells > Genox 353+ cells, IV Dl 2+ cells). These data cannot simply be explained by different antibody affinity, because in some instances (e.g., patient 5) identical or even higher percentages of positive cells were obtained with the polymorphic reagents. Fig. 1 In two normal synovial tissues derived from amputation material, the number of DR' cells was highly similar to the percentage of DQ+ cells (36% HLA-DR+/39% Leu 10+, and 40%/40%, respectively) and nearly identical to the number of Leu M3' cells (40% in both patients).
Parallel experiments investigating the Ta antigen expression of peripheral blood monocytes revealed that in normal donors (n = 9) 85±16% of the cells were DR' (reagent HLA-DR) and 27±24% expressed DQ antigens (reagent Leu 10), whereas in patients with rheumatoid arthritis (n = 9) 74±13% of the cells were DR' and 20±28% DQ+. Fig. 3 A shows the cell sorter profile of differential Ia antigen expression in peripheral blood monocytes from a normal donor, demonstrating the lower percentage as well as the lesser staining intensity of the DQ+ cells when compared with synovial cells.
In contrast to blood monocytes, peripheral blood B cells exhibited similar staining patterns for DR and DQ antigens (Fig. 3 B) indicating that the lesser fluorescence intensity in blood monocytes is not due simply to lower antibody affinity.
Synovial cells with macrophage characteristics primarily bear the DR+DQ+ phenotype; Ia+ cells without these markers are DR+DQ-. The observation of a divergence of DQ+ and DR' cells, as described above, led to the investigation of the Ta phenotype expression of the monocyte marker positive and negative synovial lining cell populations. In one set of experiments using SLC cultured for 3 h on cover slips, cells with macrophage characteristics were identified by the ingestion of Latex particles, and subsequently, cover slips were stained with the reagents HLA-DR and Leu 10, respectively. Fig. 4 illustrates that both phagocytic and nonphagocytic SLC are HLA- (Fig. 4, A and B) , whereas only the phagocytic cells depicted in Fig. 4 , C and D were positive for antibody Leu In a further experiment, double labeling was performed using the fluorescence-activated cell sorter. SLC were first stained with reagents HLA-DR or Leu 10, respectively, and then developed by fluorescein rabbit anti-mouse antibodies. Subsequently, the Leu M3 antibody tagged with phycoerythrin was added. The results of this double marker analysis are outlined in Fig. 5 peak-like staining pattern of cultured Ta' synovial fibroblasts after incubation with Interferon-y. Of particular interest are the divergent patterns of the Leu 10 staining in the two patients described. In patient B.P. (Fig. 7) there were only a few dimly stained Leu 10+ synovial fibroblasts in comparison to brightly positive fresh SLC. In contrast, in patient F.S. (Fig. 6 ) both populations intensely expressed the Leu 10 epitope. Table Ill . MU detected by reagent Leu M 3 (M4P-9). * Percentage of total cells falling under the column heading that are DR or DQ positive (first and third data columns) or that are DR or DQ negative (second and fourth data columns).
Discussion
The rheumatoid synovial tissue offers a unique opportunity to study activation mechanisms involved in an intense in vivo immune reaction that is characterized by the presence of large numbers of activated macrophages (1, 5), activated T and B lymphocytes (13, (28) (29) (30) and other cell populations (8, 9) . The marked expression of Ta antigens on many of these cells allows the investigation of a possible role of these gene products in immunoregulatory processes in an inflammatory reaction and may serve as a base line to study la induction mechanisms on the gene level. Three principal findings emerged from the present study.
(a) There are two types of Ia' synovial lining cell populations that can be discriminated on the basis ofthe level of DQ antigen expression: first, type I synovial cells with all characteristics of macrophages that express both DR and DQ antigens, and second, the monocyte marker negative type II cells characterized by the presence of large amounts of DR antigens, but low or undetectable amounts of DQ antigens.
(b) Interferon-y primarily induces the expression of DR antigens on synovial fibroblasts, while there are only small amounts of DQ antigens in the majority of experiments.
(c) These results are further confirmed using reagents with polymorphic anti-Ia specificities; they demonstrate a heterogeneity of Ta epitope expression within the DR or DQ Ta antigen families. In addition, staining with antibodies IL-R2 and 109 d6 show the presence ofthe second DR ,-chain on both freshly isolated SLC and on synovial fibroblasts after treatment with Interferon-7y.
In the present investigation, extensive efforts were made to allow a reproducible evaluation of positive cells and their degree of fluorescence intensity. Due to their large size and surface volume as well as their autofluorescence caused by cytochromes contained within the cytoplasm, synovial cells give a rather high background. This problem is best overcome using the fluorescence microscope, where it is relatively easy to distinguish between the typical rim-like staining of positive cells and the dull nonspecific whole cellular fluorescence or the cytochromes that are located in large spots within the cytoplasm frequently lighting up in different colors. Fluorescence microscopy, however, does not allow a precise quantitation of fluorescence intensity, which is best done by flow cytometry. Therefore, using fluorescence-activated cell sorter analysis, a computer program normalized the test spectrum to a control spectrum obtained with irrelevant control monoclonal antibodies ofthe same isotypes. With this combined approach, the data obtained by flow cytometry and conventional microscopy were always in accordance. To allow for a direct comparison of positive cells using the various monoclonal antibodies, all evaluations of flow cytometry were kept constant using the same gain throughout the experiments. Therefore (Fig. 3 B) strongly argue against simply a lower antibody affinity of all three reagents used to detect DQ antigens (Leu 10, Genox 3.53, and IVD 12).
In contrast to synovial macrophages characterized in the present report, peripheral blood monocytes-while DR' in the majority ofcells-express only small amounts ofDQ antigens. This has been shown in several previous studies (10, 11, 31) and was confirmed also in the rheumatoid situation in the present investigation. While entering the synovial tissue, blood monocytes apparently receive activation and/or differentiation signals that lead to an enhanced DR antigen expression as well as to a newly acquired expression of DQ antigens. This is not only true in an inflammatory reaction, but also within apparently normal synovial tissue as shown in the present report. Several observations suggest that these activation/differentiation mechanisms are not uniform in the various tissues.
Thus, alveolar macrophages, while intensely expressing both DR and DQ antigens, display a markedly reduced expression (11) . A possible candidate for an activation signal in the rheumatoid synovium appears to be Interferon-)y, which has been shown to induce DQ antigens on peripheral blood monocytes in addition to an enhanced DR antigen expression (10, 1 1) . The presence of Interferon-y has been documented both in the rheumatoid synovium (32) and the synovial fluid (33) . A possible source of this mediator may be the large number of activated Ia' T cells present in this compartment (13, 27, 34) , especially in view of the finding that Ia' T cells are the primary producers of Interferon-'y in in vitro assays (35) . (39) , on keratinocytes in lichen ruber planus (40) , and on other cell types in various autoimmune diseases (41, 42) . This expression of class II HLA antigens has been suggested to trigger the development of autoimmune diseases (43) and could be of particular importance in rheumatoid arthritis characterized by the accumulation of intensely Ia' cells in the target tissue. Of special interest, Interferon-y does not have a uniform effect on the induction of Ia antigens. Thus, in contrast to cells belonging to the monocyte or B cell lineage, this mediator does not induce DQ antigens at all on cells ofepithelial lineage ( 11) and varying but usually low amounts ofthese surface molecules on cells of mesenchymal lineage such as chondrocytes (44) or fibroblasts as shown in the present report.
It will be of particular interest to study the molecular basis ofthe differential Ia antigen induction by Interferon-ey on cells of mesenchymal lineage. Thus, as shown in the present report, most synovial fibroblasts express only low amounts of DQ antigens after Interferon-y treatment, while in some instances these antigens were intensely expressed (Fig. 7) . These data are very similar to results obtained with human articular chondrocytes incubated with Interferon-y (44) and to observations in skin fibroblast and endothelial cell cultures with IFN-y, 602 Burmester, Jahn, Rohwer, Zacher, Winchester, and Kalden shown to decrease the synthesis of types I and III collagens and fibronectin in adherent synovial cells (12) . In chondrocytes, Interferon-'y treatment changes the expression of certain surface molecules (44) . Therefore, the action of this important T cell-derived lymphokine may induce an intricate change of synovial cells resulting in both an induction ofcertain immune responses and changes of the synovial microenvironment leading to the tissue destruction characteristic of rheumatoid arthritis.
